A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)

Clinical trial NCT07139873 · RECRUITING

Trial details

NCT number: NCT07139873
Sponsor: Dizal Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Start date: 2025-09-08
Primary completion: 2029-01-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.